Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 38,678,079
- Share change
- -2,180,324
- Total reported value
- $3,475,093,026
- Put/Call ratio
- 95%
- Price per share
- $89.87
- Number of holders
- 277
- Value change
- -$190,434,872
- Number of buys
- 124
- Number of sells
- 114
Quarterly Holders Quick Answers
What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05464T104:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
9.5%
|
4,634,331
|
$373,063,646 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
3,742,002
|
$301,231,161 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
3,299,991
|
$265,649,278 | — | 30 Jun 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
4.8%
|
2,360,077
|
$189,986,199 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.8%
|
1,852,784
|
$149,149,112 | — | 30 Jun 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.2%
|
1,073,242
|
$86,396,000 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2%
|
1,000,000
|
$80,500,000 | — | 30 Jun 2024 | |
| BVF INC/IL |
13F
|
Company |
2%
|
955,000
|
$76,877,500 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
938,714
|
$75,566,477 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
938,503
|
$75,549,492 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
1.8%
|
902,136
|
$72,621,936 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.8%
|
890,985
|
$71,724,294 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
884,895
|
$71,248,564 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.5%
|
753,237
|
$60,635,579 | — | 30 Jun 2024 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
740,888
|
$59,641,484 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
739,819
|
$59,555,430 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
734,620
|
$59,136,912 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
730,000
|
$58,765,000 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
557,861
|
$44,907,813 | — | 30 Jun 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.1%
|
549,066
|
$44,199,813 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.1%
|
516,533
|
$41,580,907 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.98%
|
479,044
|
$38,563,069 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.96%
|
467,427
|
$37,627,874 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.94%
|
459,111
|
$36,958,436 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.83%
|
404,217
|
$32,539,469 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.82%
|
401,327
|
$32,306,824 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.82%
|
400,000
|
$32,200,000 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.82%
|
400,000
|
$32,200,000 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.77%
|
376,000
|
$30,268,000 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.69%
|
337,246
|
$27,148,303 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
324,493
|
$26,121,687 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
321,981
|
$25,919,473 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.65%
|
318,011
|
$25,599,886 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.63%
|
310,198
|
$24,970,939 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
309,818
|
$24,940,349 | — | 30 Jun 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
0.63%
|
306,513
|
$24,674,297 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.61%
|
300,000
|
$24,150,000 | — | 30 Jun 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.59%
|
290,772
|
$23,407,146 | — | 30 Jun 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.55%
|
269,089
|
$21,661,000 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.38%
|
184,576
|
$14,858,369 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.34%
|
168,762
|
$13,585,341 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.34%
|
168,434
|
$13,558,936 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
165,564
|
$13,327,927 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.31%
|
150,000
|
$12,075,000 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.28%
|
135,855
|
$10,936,325 | — | 30 Jun 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0.27%
|
132,705
|
$10,682,753 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.27%
|
132,312
|
$10,651,116 | — | 30 Jun 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.26%
|
127,600
|
$10,271,800 | — | 30 Jun 2024 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
0.26%
|
126,905
|
$10,215,853 | — | 30 Jun 2024 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
113,345
|
$9,077,801 | — | 30 Jun 2024 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q3 2024
As of 30 Sep 2024,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
277 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,678,079 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock, Inc., Fairmount Funds Management LLC, FMR LLC, BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., MACQUARIE GROUP LTD, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
279
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
253
Q3 2024 holders
277
Holder diff
24
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.